17-31334984-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001042492.3(NF1):c.5959C>T(p.Gln1987*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001042492.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 29
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 29
ClinVar
Submissions by phenotype
Neurofibromatosis, type 1 Pathogenic:2
- -
For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in NF1 are known to be pathogenic (PMID: 10712197, 23913538). This variant has been observed in individual(s) with neurofibromatosis type 1 (PMID: 10862084). ClinVar contains an entry for this variant (Variation ID: 620128). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gln1966*) in the NF1 gene. It is expected to result in an absent or disrupted protein product. -
NF1-related disorder Pathogenic:1
The NF1 c.5959C>T variant is predicted to result in premature protein termination (p.Gln1987*). This variant, described as c.5896C>T p.Q1966X, was reported in an individual with neurofibromatosis type 1 (Messiaen et al. 2000. PubMed ID: 10862084). This variant has not been reported in a large population database, indicating this variant is rare. In ClinVar, this variant is interpreted as pathogenic (https://preview.ncbi.nlm.nih.gov/clinvar/variation/620128/). Nonsense variants in NF1 are expected to be pathogenic. This variant is interpreted as pathogenic. -
not provided Pathogenic:1
The Q1966X nonsense variant in the NF1 gene has been reported previously in association with neurofibromatosis type 1 (Messiaen et al., 2000). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. This variant is not observed in large population cohorts (Lek et al., 2016). We classify this variant as pathogenic. -
Hereditary cancer-predisposing syndrome;CN230736:Cardiovascular phenotype Pathogenic:1
The p.Q1966* pathogenic mutation (also known as c.5896C>T), located in coding exon 39 of the NF1 gene, results from a C to T substitution at nucleotide position 5896. This changes the amino acid from a glutamine to a stop codon within coding exon 39. This variant, also reported as p.Q1966X, has been observed in at least one individual with a personal and family history that is consistent with Neurofibromatosis type 1 (Ambry internal data; Messiaen LM et al. Hum Mutat, 2000;15:541-55). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at